In emails to Klimas and C&EN, Regeneron staff cite the ... themselves can be used to find out how long COVID works. If an antiviral or monoclonal antibody that targets SARS-CoV-2 manages to ...

A German court ruled that Pfizer and BioNTech infringed Moderna's COVID-19 vaccine patent ... an immunomodulatory agent and an anti-CD38 monoclonal antibody, and have demonstrated disease ...

Yancopoulos, Regeneron’s chief scientific officer ... technologies to deliver the first FDA-approved recombinant monoclonal antibody treatment for any viral disease, and they picked one of ...

In addition to INO-3107, Inovio has made significant strides with its proprietary DNA-encoded monoclonal antibody (DMAb ... functional antibodies against COVID-19, with notable durability lasting ...

Guttman-Yassky received research support, consulting, or lecture fees on atopic dermatitis from Regeneron, Sanofi, Pfizer, ...

The company’s proprietary technology platforms, including its DNA-encoded monoclonal antibody (DMAb ... DMAb Platform and COVID-19 Antibodies Inovio’s DMAb platform has shown promising ...

A German court ruled that Pfizer and BioNTech infringed Moderna's COVID-19 vaccine patent ... an immunomodulatory agent and an anti-CD38 monoclonal antibody, and have demonstrated disease ...

2-adapted COVID-19 vaccines across different countries and regions ... BNT316/ONC-392 (gotistobart) is an anti-CTLA-4 monoclonal antibody candidate being developed in collaboration with OncoC4, Inc. ( ...

Mergers and acquisitions grabbed the spotlight in the biotech sector this week after Jazz Pharmaceuticals JAZZ announced an agreement to acquire Chimerix CMRX. Meanwhile, other pipeline and regulatory ...

Regeneron, Lilly, and GSK don’t have new COVID-19 treatments in their clinical pipelines anymore. Vir Biotechnology, which had codeveloped a monoclonal antibody with GSK, changed business strategies ...

In addition to INO-3107, Inovio has made significant strides with its proprietary DNA-encoded monoclonal antibody (DMAb) platform. Recent clinical data has demonstrated the platform’s ability to ...